Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”), in accordance with DTR 5.6.1 of the FSA’s Disclosure and Transparency Rules, notifies the market of the following:
At close of business on October 31, 2012, the Company’s issued share capital consisted of 562,192,259 ordinary shares of 5 pence each with voting rights and a further 346,099 ordinary shares held in treasury.
Therefore the total number of voting rights in the Company is 562,192,259. This is the figure which should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
|Eric Rojas||[email protected]||+1 781 482 0999|
|Sarah Elton-Farr||[email protected]||+44 1256 894157|
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
as well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.